Early results of the randomized, multicenter, controlled evaluation of S-1 and oxaliplatin as neoadjuvant chemotherapy for Chinese advanced gastric cancer patients (RESONANCE Trial)

被引：4
|
作者：
Wang, Xinxin
Li, Shuo
Xie, Tianyu
Lu, Yixun
Guo, Xin
Lin, Chen
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
280
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with 2 and 4 courses of cisplatin/S-1 (CS) and docetaxel/cisplatin/S-1 (DCS) as neoadjuvant chemotherapy for locally advanced gastric cancer
    Nishikawa, K.
    Yoshikawa, T.
    Fujitani, K.
    Tanabe, K.
    Ito, S.
    Matsui, T.
    Miki, A.
    Nemoto, H.
    Sakamaki, K.
    Cho, H.
    Fukunaga, T.
    Kimura, Y.
    Hirabayashi, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Final results of a phase II multicenter study of neoadjuvant S-1 and irinotecan in patients with locally advanced gastric cancer
    Terashima, Masanori
    Saze, Zenichiro
    Hosotani, Ryo
    Takahashi, Masahiro
    Takagane, Akinori
    Hachiya, Osamu
    Koeda, Keisuke
    Matsui, Shigeyuki
    Fukushima, Norimasa
    Kawasaki, Hitoshi
    Gotoh, Mitsukazu
    Fukushima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [33] Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients
    Mitsuhiko Ota
    Hiroshi Saeki
    Hideo Uehara
    Yoshiko Matsuda
    Satoshi Tsutsumi
    Tetsuya Kusumoto
    Hisateru Yasui
    Yasunari Ubukata
    Shohei Yamaguchi
    Hiroyuki Orita
    Naoki Izawa
    Saburo Kakizoe
    Mototsugu Shimokawa
    Tomoharu Yoshizumi
    Yoshihiro Kakeji
    Masaki Mori
    Eiji Oki
    International Journal of Clinical Oncology, 2023, 28 : 1166 - 1175
  • [34] Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial
    Hu, Xiang
    Chen, Lin
    Du, Yian
    Fan, Biao
    Bu, Zhaode
    Wang, Xin
    Ye, Yingjiang
    Zhang, Zhongtao
    Xiao, Gang
    Li, Fei
    He, Qingsi
    Li, Guoli
    Shen, Xian
    Xiong, Bin
    Zhu, Liming
    Liu, Jiwei
    Liu, Lian
    Wu, Tao
    Zhou, Jing
    Zhang, Jun
    Zhao, Gang
    Wang, Xulin
    Liang, Pin
    Wang, Xinxin
    Zhang, Yan
    Wu, Xiaojiang
    Zhang, Ji
    Ji, Xin
    Zong, Xianglong
    Fu, Tao
    Jia, Ziyu
    Ji, Jiafu
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (02) : 144 - 148
  • [35] Primary results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for advanced gastric cancer
    Hayashi, Tsutomu
    Yoshikawa, Takaki
    Sakamaki, Kentaro
    Nishikawa, Kazuhiro
    Fujitani, Kazumasa
    Tanabe, Kazuaki
    Misawa, Kazunari
    Matsui, Takanori
    Miki, Akira
    Nemoto, Hiroshi
    Fukunaga, Tetsu
    Kimura, Yutaka
    Hihara, Jun
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2020, 4 (05): : 540 - 548
  • [36] S-1 with leucovorin and oxaliplatin for advanced gastric cancer
    ter Veer, Emil
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    LANCET ONCOLOGY, 2016, 17 (02): : E41 - E41
  • [37] S-1 plus oxaliplatin compared with fluorouracil/leucovorin/oxaliplatin as neoadjuvant chemotherapy for locally advanced gastric carcinoma.
    Yu, Jiren
    Wu, Yijun
    Gao, Yuan
    Shen, Qianyun
    Zhang, Qing
    Liu, Xiaosun
    Zhu, Kankai
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [38] Adjuvant chemotherapy for chemotherapy-naive advanced gastric cancer patients with oxaliplatin plus tegafur versus oxaliplatin plus S-1
    Shu, Zhenbo
    Ding, Dayong
    Li, Yongchao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (06): : 9322 - 9329
  • [39] Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Yook, Jeong Hwan
    Park, Young-Kyu
    Kim, Young-Woo
    Kim, Jin Young
    Ryu, Min-Hee
    Rha, Sun Young
    Chung, Ik-Joo
    Kim, In-Ho
    Oh, Sang Cheul
    Yoo, Chang Hak
    Kang, Seok Yun
    Zang, Dae Young
    Kim, Sunju
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Sato, Hirohiko
    Shimada, Mitsuo
    Kurita, Nobuhiro
    Iwata, Takashi
    Yoshikawa, Kozo
    Higashigima, Jun
    Chikakio, Motoya
    Kashihara, Hideya
    Takasu, Chie
    Matsumoto, Noriko
    Eto, Shozo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 543 - 548
12345